Welcome to our dedicated page for NextPlat news (Ticker: NXPL), a resource for investors and traders seeking the latest updates and insights on NextPlat stock.
NextPlat Corp reports developments across a healthcare and e-commerce business that provides healthcare and technology solutions through retail and online channels. Recurring news includes financial results, margin and expense updates, 340B covered-entity activity, contracted healthcare services, and prescription fulfillment through its PharmcoRx subsidiary.
Company updates also cover e-commerce and communications products, including voice, data, tracking, and satellite-enabled IoT offerings through Global Telesat Communications. Other recurring themes include AI-enabled pharmacy processing tools, customer and contract activity, Nasdaq listing compliance, and capital-structure actions such as share adjustments and warrant-related disclosures.
NextPlat (NASDAQ: NXPL) said its PharmcoRx subsidiary has deployed AI-powered prescription in-take and processing technology into its pharmacy management system effective April 16, 2026. The tools automate data entry, faxing and refill management, create HIPAA-compliant digital workflows and support scaled fulfillment for new contracted clients.
NextPlat (NASDAQ: NXPL) said its Global Telesat Communications subsidiary received new satellite-enabled IoT orders of approximately $400,000, supporting a military end-user in Eastern Europe and a new customer in Asia. The orders follow a prior $820,000 contract for a NATO military customer.
Through Q1 2026, GTC's government and military IoT product orders totalled more than $1.2 million, which the company cites as momentum for 2026 growth alongside healthcare expansion.
NextPlat (NASDAQ: NXPL) announced a 1-for-10 reverse stock split effective at 12:01 AM ET on April 13, 2026. Every ten pre-split shares will be consolidated into one post-split share, reducing outstanding shares from approximately 26.9 million to approximately 2.7 million.
The company's common stock will open for trading on The Nasdaq Global Market on April 13, 2026 on a post-split basis under the existing ticker NXPL and a new CUSIP 68557F 308. Fractional shares will be settled for cash in lieu; authorized shares remain at 50 million and par value stays at $0.0001.
NextPlat (NASDAQ: NXPL) reported consolidated revenue of $54.3 million for 2025, down 18% year-over-year, driven by lower prescription volume. Healthcare revenue was $39.7 million and e-commerce revenue was $14.6 million. Gross margin declined to ~20% from 26% in 2024.
Operating expenses fell ~50% to $19.9 million; net loss attributable to common stockholders was $11.7 million or ($0.44) per diluted share. The company ended 2025 with ~$13.7 million cash, no meaningful unsecured debt, and ~$15.0 million working capital, and said cost-cutting and 340B/fulfillment focus will support 2026 profitability.
NextPlat (NASDAQ: NXPL) announced a 1-for-10 reverse stock split effective 12:01 a.m. ET on April 6, 2026, with split-adjusted trading to begin on Nasdaq on April 7, 2026 under the existing ticker NXPL.
The split will reduce outstanding shares from 27,026,215 to approximately 2,702,621, cashed-out fractional shares, will not reduce authorized shares, and aims to regain compliance with Nasdaq's minimum bid price requirement.
NextPlat (NASDAQ: NXPL) announced a collaboration with HealthWarehouse to enable nationwide prescription and OTC fulfillment to all 50 U.S. states, expanding PharmcoRx beyond Florida.
The agreement leverages HealthWarehouse's NABP‑accredited digital pharmacy and national fulfillment to support rapid e-commerce expansion and revenue growth in 2026.
NextPlat (NASDAQ: NXPL) will release full-year 2025 financial results on Tuesday, March 31, 2026. Management will host a conference call at 8:30 a.m. Eastern to discuss results and recent developments.
Investors must submit Q&A questions by March 27, 2026 to investors@nextplat.com. The live webcast and replay will be available via the company webcast link and the investor relations site; phone dial-in and replay numbers are provided.
NextPlat (NASDAQ: NXPL) announced that its Global Telesat Communications subsidiary was awarded a two-year contract worth up to $820,000 from a U.K. government prime supplier to supply satellite-enabled IoT hardware in support of a NATO military end user.
The program uses Iridium Certus dual-mode satellite and LTE terminals for voice, data, and asset management to enable resilient, global connectivity.
NextPlat (NASDAQ: NXPL) expanded Orbital Satcom into South America by launching online storefronts on Mercado Libre in Mexico, Brazil, Argentina, Chile and Colombia.
The sites offer satellite and wireless connectivity products using Globalstar, Iridium and Inmarsat, target millions of customers, and plan further country rollouts in Q2 2026.
NextPlat (NASDAQ: NXPL) expects approximately $55 million in 2025 revenue and reports sequential Q4 2025 improvement versus Q3 driven by higher-margin 340B and contracted services.
Key metrics: 340B revenue +90% QoQ, prescription volume +7% sequentially, anticipated Q1 2026 consolidated gross margin of 20%-25%, cash ~$13M, working capital ~$15M, and zero unsecured debt. Results are preliminary and subject to audit; Form 10-K expected by March 31, 2026.